These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35306635)

  • 1. Should Doctors Offer Biomarker Testing to Those Afraid to Develop Alzheimer's Dementia? : Applying the Method of Reflective Equilibrium for a Clinical Dilemma.
    Smedinga M; Bunnik EM; Richard E; Schermer MHN
    J Bioeth Inq; 2022 Jun; 19(2):287-297. PubMed ID: 35306635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical Arguments Concerning the Use of Alzheimer's Disease Biomarkers in Individuals with No or Mild Cognitive Impairment: A Systematic Review and Framework for Discussion.
    Smedinga M; Tromp K; Schermer MHN; Richard E
    J Alzheimers Dis; 2018; 66(4):1309-1322. PubMed ID: 30507575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the Ethical Issues of a Biomarker-Based Diagnoses in the Early Stage of Alzheimer's Disease.
    Vanderschaeghe G; Dierickx K; Vandenberghe R
    J Bioeth Inq; 2018 Jun; 15(2):219-230. PubMed ID: 29532386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues.
    Porteri C; Albanese E; Scerri C; Carrillo MC; Snyder HM; Martensson B; Baker M; Giacobini E; Boccardi M; Winblad B; Frisoni GB; Hurst S;
    Neurobiol Aging; 2017 Apr; 52():132-140. PubMed ID: 28317644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer's Disease Neuroimaging Initiative.
    Spencer BE; Jennings RG; Brewer JB;
    J Alzheimers Dis; 2019; 68(4):1549-1559. PubMed ID: 30958366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations regarding a diagnosis of Alzheimer's disease before dementia: a systematic review.
    van der Schaar J; Visser LNC; Bouwman FH; Ket JCF; Scheltens P; Bredenoord AL; van der Flier WM
    Alzheimers Res Ther; 2022 Feb; 14(1):31. PubMed ID: 35144684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Views on Early Diagnosis of Alzheimer's Disease Among Dutch Physicians: A Qualitative Interview Study.
    Tromp K; Smedinga M; Richard E; Perry M; Schermer MHN
    J Alzheimers Dis; 2021; 79(2):917-927. PubMed ID: 33361592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
    Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC;
    Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment: the Manchester consensus.
    Dunne RA; Aarsland D; O'Brien JT; Ballard C; Banerjee S; Fox NC; Isaacs JD; Underwood BR; Perry RJ; Chan D; Dening T; Thomas AJ; Schryer J; Jones AM; Evans AR; Alessi C; Coulthard EJ; Pickett J; Elton P; Jones RW; Mitchell S; Hooper N; Kalafatis C; Rasmussen JGC; Martin H; Schott JM; Burns A
    Age Ageing; 2021 Jan; 50(1):72-80. PubMed ID: 33197937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.
    Henriques AD; Benedet AL; Camargos EF; Rosa-Neto P; Nóbrega OT
    Exp Gerontol; 2018 Jul; 107():169-177. PubMed ID: 29307736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.
    Garrett MD; Valle R
    Dementia (London); 2016 Mar; 15(2):239-54. PubMed ID: 24662500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.
    Ossenkoppele R; van der Kant R; Hansson O
    Lancet Neurol; 2022 Aug; 21(8):726-734. PubMed ID: 35643092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advance directives as a tool to respect patients' values and preferences: discussion on the case of Alzheimer's disease.
    Porteri C
    BMC Med Ethics; 2018 Feb; 19(1):9. PubMed ID: 29458429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
    Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
    J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects.
    Rostamzadeh A; Schwegler C; Gil-Navarro S; Rosende-Roca M; Romotzky V; Ortega G; Canabate P; Moreno M; Schmitz-Luhn B; Boada M; Jessen F; Woopen C
    J Alzheimers Dis; 2021; 80(2):601-617. PubMed ID: 33554900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients.
    Gündüztepe Y; Bukan N; Zorlu E; Karaman Y; Andaç Topkan T; Gurbuz N; Neşelioğlu S; Erel Ö
    J Clin Neurosci; 2020 May; 75():188-194. PubMed ID: 32223973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
    Molinuevo JL; Blennow K; Dubois B; Engelborghs S; Lewczuk P; Perret-Liaudet A; Teunissen CE; Parnetti L
    Alzheimers Dement; 2014 Nov; 10(6):808-17. PubMed ID: 25150736
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.